Cervical Length Measurement Timing for Preterm Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the optimal timing for measuring cervical length during pregnancy scans to predict early birth risk. Researchers are testing whether measurements taken at the start or end of the scan yield better results. They are also comparing two types of ultrasound images: regular grayscale and sepia-filtered. Pregnant individuals between 16 and 23 weeks, attending specific clinics, and consenting to an internal ultrasound, can participate. This research aims to enhance prenatal care by improving early birth risk assessments. As an unphased trial, it allows participants to contribute to advancements in prenatal care without the constraints of traditional clinical trial phases.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on measuring cervical length during pregnancy and does not mention any medication restrictions.
What prior data suggests that this cervical length measurement technique is safe for pregnant individuals?
Research shows that measuring cervical length with a transvaginal ultrasound is an important predictor of early birth in pregnant individuals. Studies have found this method effective in identifying those at risk for early labor. This procedure is generally comfortable and does not introduce additional risks beyond regular prenatal care.
Patients who previously had their cervical length measured did not experience significant negative effects, confirming its safety for monitoring during pregnancy. The trial aims to determine the optimal timing for measuring cervical length to achieve the most accurate results. Researchers will test different timings and imaging methods, but the safety of the measurement itself is well-established.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the optimal timing for cervical length measurement to predict preterm birth risk. Unlike standard practices that may not specify the timing of these measurements during the anatomy survey, this trial tests whether taking measurements at the beginning versus the end can improve adherence to the CLEAR criteria for accuracy. By using both grayscale and sepia-filtered ultrasound imaging, the trial aims to enhance the precision of cervical length assessments, potentially leading to better early detection and management of preterm birth risks.
What evidence suggests that this trial's cervical length measurement methods could be effective for improving preterm birth risk assessment?
Research has shown that checking cervical length can help predict early births. One study found that measuring it once between 18 and 24 weeks of pregnancy is effective. This approach might be more effective than multiple checks. Another study found that using a transvaginal ultrasound to measure cervical length is especially helpful for women expecting twins. In this trial, participants will be divided into two groups: one group will have cervical length measured at the start of the anatomy scan, and the other at the end. The trial examines whether the timing of the measurement affects accuracy and if sepia-toned images improve accuracy compared to regular black-and-white images.678910
Who Is on the Research Team?
Raminder Khangura, MD
Principal Investigator
Henry Ford Health
Are You a Good Fit for This Trial?
This trial is for pregnant individuals undergoing routine fetal anatomy surveys. It's designed to find the best time to measure cervical length, which helps predict preterm birth risk. Participants must consent to a transvaginal ultrasound and be okay with being randomly assigned when their cervical length will be measured.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Intervention
Participants are randomized to have cervical length measured at either the start or end of the anatomy survey using both grayscale and sepia-filtered ultrasound imaging.
Data Collection and Analysis
Cervical length measurements are collected and analyzed for adherence to the nine CLEAR criteria.
Follow-up
Participants are monitored for any adverse effects and the study outcomes are evaluated.
What Are the Treatments Tested in This Trial?
Interventions
- Cervical Length Measurement
Trial Overview
The study tests whether measuring cervical length at the start or end of an anatomy survey affects its accuracy, using both grayscale and sepia-filtered ultrasound images. The goal is to determine if timing and imaging method can improve detection of potential preterm births.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants in this arm will undergo cervical length measurement via transvaginal ultrasound at the end of the fetal anatomy survey. This timing aims to evaluate whether late measurement improves adherence to the nine CLEAR criteria for accurate cervical length assessment. Measurements will also be conducted using grayscale and sepia-filtered ultrasound imaging.
Participants in this arm will undergo cervical length measurement via transvaginal ultrasound at the start of the fetal anatomy survey. This timing aims to evaluate whether early measurement improves adherence to the nine CLEAR criteria for accurate cervical length assessment. Measurements will also be conducted using grayscale and sepia-filtered ultrasound imaging.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
Published Research Related to This Trial
Citations
A SYSTEMATIC REVIEW AND META-ANALYSIS
A single cervical length measurement obtained between 18–24 weeks of gestation appears to be a better test to predict preterm birth than changes in cervical ...
Universal cervical length screening and risk of ...
In the overall analysis, universal transvaginal ultrasound cervical length did not significantly decrease the spontaneous preterm birth rates <37 weeks (odds ...
Mid-trimester prediction of spontaneous preterm birth with ...
The objective of this study was to evaluate a novel automated test based on ultrasound cervical texture analysis to predict spontaneous Preterm Birth (sPTB)
The role of routine cervical length screening in selected high
The purpose of this document is to review the indications and rationale for cervical length screening to prevent preterm birth in various clinical scenarios.
TRANSVAGINAL SONOGRAPHIC CERVICAL LENGTH ...
Transvaginal sonographic CL 20-24 weeks' gestation is a good predictor of spontaneous preterm birth in asymptomatic women with twin pregnancies.
Universal Cervical Length Screening: Implementation and ...
Rates of spontaneous preterm birth before 28 weeks were higher in those who declined cervical length screening (aOR 2.01, 95% CI 1.33, 3.02). Conclusion.
Transvaginal cervical length measurement for prediction of ...
A cut-off of 15 mm for cervical length (three studies, 1266 women, rate of preterm birth within 48 h 7.1%) predicted 71.1% (95% CI, 59.5–80.9%) ...
8.
bmcpregnancychildbirth.biomedcentral.com
bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-025-08210-xFirst-trimester cervical length screening and the risk of preterm ...
The analysis revealed that pregnant individuals who underwent PTB before 37- and 34-weeks' gestation exhibited significantly shorter CL during ...
9.
sdms.org
sdms.org/docs/default-source/jdmspdf/serial-cervical-length-measurement-for-determining.pdf?sfvrsn=2Serial Cervical Length Measurement for Determining the ...
Objective: This study aimed to evaluate whether serial evaluations of cervical length (CL) have the potential to determine preterm labor in women with ...
SMFM Consult Series #70: Management of short cervix in ...
Midtrimester cervical length assessment using transvaginal ultrasound is one of the best clinical predictors of spontaneous preterm birth. This ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.